By proceeding, you agree to our Terms of Use and Privacy Policy.
CELLINK is proud to be a part of BICO, the world’s leading bioconvergence company.
10-12 May 2022
Following the FDA’s announcement of ‘Alternative Methods Working Group’ in the summer, 2021, Roche’s newly opened pRED Innovation Center in Basel, and exciting data from Recce Pharma’s anti-infective candidate using organoids, the 7th Annual 3D Tissu
Event Ended
USA
Paid
Boston
16-18 May 2023
Revolutionizing Drug Discovery & Development with Advanced 3D Models In light of recent advancements, including the FDA Modernization Act 2.0 signed by President Biden in December 2022, the successful IND approval for a Phase 2 clinical trial using o